A trial of epacadostat for women who have a raised level of CA125 after treatment for ovarian, primary peritoneal or fallopian tube cancer

This trial looked at a drug called epacadostat for women with ovarian cancer who had no signs of cancer after chemotherapy. But who then had a raised level of a marker called CA125 in their blood a few months later. The trial was for women who had:

• ovarian cancer

• primary peritoneal cancer

• fallopian tube cancer

These cancers are all treated in the same way. So, when we use the term ovarian cancer in this summary, we are referring to all 3.